While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

The company will compete with a device Boston Scientific acquired for $850 million.

A jury found that Biosense Webster withheld services to hospitals using reprocessed catheters.

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient ...

CEO Bryan Hanson said tariffs have given “a higher sense of urgency” to the company’s existing efforts to regionalize its ...